Combination therapy for inflammatory bowel disease

Biologic therapies such as infliximab and adalimumab have become mainstays of treatment for inflammatory bowel disease. Early studies suggested that combination therapy (CT) with infliximab and an immunomodulator drug such as azathioprine may help optimize biologic pharmacokinetics, minimize immunog...

Descripción completa

Detalles Bibliográficos
Autores principales: Sultan, Keith S, Berkowitz, Joshua C, Khan, Sundas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421108/
https://www.ncbi.nlm.nih.gov/pubmed/28533919
http://dx.doi.org/10.4292/wjgpt.v8.i2.103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421108/
https://www.ncbi.nlm.nih.gov/pubmed/28533919
http://dx.doi.org/10.4292/wjgpt.v8.i2.103

Ejemplares similares